The Defense Health Agency awarded a $1,346,633 Project Grant to the George Washington University under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research titled "A PRIMARY ROLE FOR THE CIRCULATORY MICROENVIRONMENT IN AFRICAN AMERICAN PROSTATE CANCER DISPARITIES?" from May 15, 2023 to May 14, 2026. As the prime awardee, George Washington University will investigate medical solutions for prostate cancer disparities affecting African...
The Defense Health Agency has awarded a $723,991 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Mayo Clinic Jacksonville (A Nonprofit Corporation), doing business as Scott Lynch MD, located in Jacksonville, Florida. The grant, titled "The Inclusive Cancer Care Research Equity (ICCARE) for Black Men Consortium," will fund research to transform healthcare for military service members and the public through innovative and impactful cancer...
This Project Grant from the Defense Health Agency provides $268,155 to Covenant University in Nigeria to establish the Inclusive Cancer Care Research Equity for Black Men Consortium. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform military and public health care. Specifically, the consortium will conduct applied research to investigate medical solutions for cancer in Black men and promote equitable...
The U.S. Department of the Army Medical Command awarded a $4,623,272 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Mayo Clinic Jacksonville (A Nonprofit Corporation), doing business as Scott Lynch MD. The grant, titled "The Inclusive Cancer Care Research Equity (ICCARE) for Black Men Consortium," will support advanced biomedical research focused on transforming healthcare for military service members and the broader public. The four-year...
This federal Project Grant award, titled "THE INCLUSIVE CANCER CARE RESEARCH EQUITY (ICCARE) FOR BLACK MEN CONSORTIUM", is funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The $480,111 award to Mayo Clinic Jacksonville, a nonprofit healthcare organization, will support advanced biomedical research focused on transforming healthcare for military service members and the broader public. The research, with a...
The U.S. Department of Defense's Defense Health Agency has awarded a $762,168 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a project period from September 30, 2023 to September 29, 2026, is intended to "DECONVOLUTE KEY BIOLOGICAL DRIVERS THAT DEFINE SUBSETS OF LETHAL PROSTATE CANCER IN AFRICAN AMERICAN MEN." As a leading National Cancer...
The Department of the Army Medical Command awarded a $1,065,567 project grant to Baylor College of Medicine to develop a novel therapeutic strategy for prostate cancer in African American men. The grant was awarded under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative and impactful medical solutions. Funding will support Baylor College of Medicine's...
The Department of the Army Medical Command awarded a $773,102 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Mayo Clinic Jacksonville (A Nonprofit Corporation), doing business as Scott Lynch MD. The grant, titled "The Inclusive Cancer Care Research Equity (ICCARE) for Black Men Consortium", is for the period of September 30, 2024 to September 29, 2028. The grant supports advanced biomedical research initiatives focused on transforming...
This $459,360 federal Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, FL. The grant supports advanced biomedical research initiatives focused on investigating the genetic risk of prostate cancer in self-identified Black veterans. The project will be conducted over a 3-year period from July 1, 2025 to June 30, 2028. As a National...
This $1,323,505 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research to explore immune-tumor cell metabolic interactions in prostate cancer among African American men. The grant recipient, Trustees of Indiana University, will leverage its expertise in biomedical sciences and public health to conduct this innovative research initiative. The award has a performance period from August 1, 2024 to July 31, 2027....